Jay Moyes
Director/Board Member at BIOCARDIA INC
Net worth: 322 653 $ as of 2024-02-28
Profile
Jay M.
Moyes is on the board of Puma Biotechnology, Inc. and BioCardia, Inc. and Member of Utah Association of Certified Public Accountants and Managing Member at Drayton Investments LLC.
In the past he held the position of Chief Financial Officer for Myriad Genetics, Inc., Chief Financial Officer at CareDx, Inc., Chief Financial Officer & Director at SINTX Technologies, Inc., Chief Financial Officer of Sera Prognostics, Inc., Chief Financial Officer & Vice President-Finance of Genmarks, Inc. and Senior Manager at KPMG LLP.
He received an MBA from the University of Utah and an undergraduate degree from Weber State University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
0.09% | 2023-06-12 | 43,322 ( 0.09% ) | 269 463 $ | 2024-02-28 |
BIOCARDIA, INC.
0.20% | 2023-10-17 | 50,812 ( 0.20% ) | 27 947 $ | 2024-02-28 |
2023-03-30 | 2,830 ( 0.01% ) | 25 244 $ | 2024-02-28 | |
2023-04-12 | 0 ( -.--% ) | - $ | 2024-02-28 |
Jay Moyes active positions
Companies | Position | Start |
---|---|---|
PUMA BIOTECHNOLOGY, INC. | Director/Board Member | 2012-04-26 |
BIOCARDIA INC | Director/Board Member | 2010-12-31 |
Drayton Investments LLC | Corporate Officer/Principal | - |
Utah Association of Certified Public Accountants | Corporate Officer/Principal | 2010-06-02 |
Former positions of Jay Moyes
Companies | Position | End |
---|---|---|
ACHIEVE LIFE SCIENCES, INC. | Director/Board Member | 2023-06-06 |
SERA PROGNOSTICS, INC. | Director of Finance/CFO | 2023-06-06 |
PREDICTIVE TECHNOLOGY GROUP, INC. | Director/Board Member | 2019-11-30 |
OSIRIS THERAPEUTICS, INC. | Director/Board Member | 2017-12-12 |
Integrated Diagnostics, Inc.
Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Director/Board Member | 2016-10-31 |
Training of Jay Moyes
University of Utah | Masters Business Admin |
Weber State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 8 |
---|---|
MYRIAD GENETICS, INC. | Health Technology |
CAREDX, INC | Health Technology |
SINTX TECHNOLOGIES, INC. | Health Technology |
PREDICTIVE TECHNOLOGY GROUP, INC. | Health Technology |
SERA PROGNOSTICS, INC. | Health Services |
PUMA BIOTECHNOLOGY, INC. | Health Technology |
BIOCARDIA INC | Health Technology |
ACHIEVE LIFE SCIENCES, INC. | Health Technology |
Private companies | 8 |
---|---|
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Genmarks, Inc.
Genmarks, Inc. Engineering & ConstructionIndustrial Services Part of Nutrien Ltd., Genmarks, Inc. is a private company that specializes in developing and commercializing molecular diagnostic solutions. The company is based in Greeley, CO. | Industrial Services |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Integrated Diagnostics, Inc.
Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Health Services |
Utah Life Science Association | Commercial Services |
Utah Association of Certified Public Accountants | |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Health Technology |
Drayton Investments LLC |